skip to main content

Title: Treatment of Anthrax Disease Frequently Asked Questions

This document provides a summary of Frequently Asked Questions (FAQs) on the treatment of anthrax disease caused by a wide-area release of Bacillus anthracis spores as an act bioterrorism. These FAQs are intended to provide the public health and medical community, as well as others, with guidance and communications to support the response and long-term recovery from an anthrax event.
Authors:
; ; ;
Publication Date:
OSTI Identifier:
992013
Report Number(s):
PNNL-18710
400403909; TRN: US201023%%369
DOE Contract Number:
AC05-76RL01830
Resource Type:
Technical Report
Research Org:
Pacific Northwest National Laboratory (PNNL), Richland, WA (US)
Sponsoring Org:
USDOE
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 99 GENERAL AND MISCELLANEOUS//MATHEMATICS, COMPUTING, AND INFORMATION SCIENCE; BACILLUS; COMMUNICATIONS; DISEASES; PUBLIC HEALTH; SPORES anthrax; bacillus anthracis; ciprofloxacin; doxycycline; anthrax vaccine